嘌呤2'-脱氧核糖核苷
描述:
由嘌呤与缺乏2位羟基的核糖连接而成的化合物。
上级分类:
热门产品
-
5'-O-TBDMS-dGCAS: 51549-33-8 分子式: C16H27N5O4Si 分子量: 381.50有现货 货号: C980863查看产品价格与包装技术标识符
- IUPAC名称
- 2-amino-9-[(2R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]-1H-purin-6-one
- SMILES
- CC(C)(C)[Si](C)(C)OC[C@@H]1[C@H](C[C@@H](O1)N2C=NC3=C2N=C(NC3=O)N)O
- InChIKey
- SEYILVDPIQPEAP-HBNTYKKESA-N
- InChI
- 1S/C16H27N5O4Si/c1-16(2,3)26(4,5)24-7-10-9(22)6-11(25-10)21-8-18-12-13(21)19-15(17)20-14(12)23/h8-11,22H,6-7H2,1-5H3,(H3,17,19,20,23)/t9-,10+,11+/m0/s1
-
2'-Deoxy-2-methoxyadenosineCAS: 24757-70-8 化合物 CID: 10265713期货 货号: D1327601查看产品价格与包装技术标识符
- IUPAC名称
- (2R,3S,5R)-5-(6-amino-2-methoxypurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
- SMILES
- COC1=NC(=C2C(=N1)N(C=N2)C3CC(C(O3)CO)O)N
- InChIKey
- HGRICISHTIAZJG-RRKCRQDMSA-N
- InChI
- 1S/C11H15N5O4/c1-19-11-14-9(12)8-10(15-11)16(4-13-8)7-2-5(18)6(3-17)20-7/h4-7,17-18H,2-3H2,1H3,(H2,12,14,15)/t5-,6+,7+/m0/s1
-
((2R,3R,4S,5R)-3-(Benzoyloxy)-5-(6-chloro-9H-purin-9-yl)-4-fluorotetrahydrofuran-2-yl)methyl benzoate期货 货号: R1013551查看产品价格与包装技术标识符
- IUPAC名称
- [(2R,3R,4S,5R)-3-benzoyloxy-5-(6-chloropurin-9-yl)-4-fluorooxolan-2-yl]methyl benzoate
- SMILES
- C1=CC=C(C=C1)C(=O)OCC2C(C(C(O2)N3C=NC4=C3N=CN=C4Cl)F)OC(=O)C5=CC=CC=C5
- InChIKey
- UUXIUBHNOYWBNO-ZRAXVTTISA-N
- InChI
- 1S/C24H18ClFN4O5/c25-20-18-21(28-12-27-20)30(13-29-18)22-17(26)19(35-24(32)15-9-5-2-6-10-15)16(34-22)11-33-23(31)14-7-3-1-4-8-14/h1-10,12-13,16-17,19,22H,11H2/t16-,17+,19-,22-/m1/s1
-
2'-Chloro-2'-deoxyadenosineCAS: 2627-62-5 化合物 CID: 100327期货 货号: C996024查看产品价格与包装技术标识符
- IUPAC名称
- (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-chloro-2-(hydroxymethyl)oxolan-3-ol
- SMILES
- C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)Cl)N
- InChIKey
- ADXUXRNLBYKGOA-QYYRPYCUSA-N
- InChI
- 1S/C10H12ClN5O3/c11-5-7(18)4(1-17)19-10(5)16-3-15-6-8(12)13-2-14-9(6)16/h2-5,7,10,17-18H,1H2,(H2,12,13,14)/t4-,5-,7-,10-/m1/s1
-
2'-氨基-2'-脱氧腺苷CAS: 10414-81-0 分子式: C10H14N6O3 分子量: 266.26有现货 货号: A736576查看产品价格与包装技术标识符
- IUPAC名称
- (2R,3S,4R,5R)-4-amino-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
- SMILES
- C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)N)N
- InChIKey
- CQKMBZHLOYVGHW-QYYRPYCUSA-N
- InChI
- 1S/C10H14N6O3/c11-5-7(18)4(1-17)19-10(5)16-3-15-6-8(12)13-2-14-9(6)16/h2-5,7,10,17-18H,1,11H2,(H2,12,13,14)/t4-,5-,7-,10-/m1/s1
-
N6-苯甲酰-2'-氟脱氧腺苷期货 货号: B692684查看产品价格与包装技术标识符
- IUPAC名称
- N-[9-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]benzamide
- SMILES
- C1=CC=C(C=C1)C(=O)NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)F
- InChIKey
- HLJZTLWDAQVZBU-YAMOITTJSA-N
- InChI
- 1S/C17H16FN5O4/c18-11-13(25)10(6-24)27-17(11)23-8-21-12-14(19-7-20-15(12)23)22-16(26)9-4-2-1-3-5-9/h1-5,7-8,10-11,13,17,24-25H,6H2,(H,19,20,22,26)/t10-,11-,13-,17-/m1/s1
-
2'-脱氧-6-O-甲基-鸟苷期货 货号: D694426查看产品价格与包装技术标识符
- IUPAC名称
- (2R,3S,5R)-5-(2-amino-6-methoxypurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
- SMILES
- COC1=NC(=NC2=C1N=CN2C3CC(C(O3)CO)O)N
- InChIKey
- BCKDNMPYCIOBTA-RRKCRQDMSA-N
- InChI
- 1S/C11H15N5O4/c1-19-10-8-9(14-11(12)15-10)16(4-13-8)7-2-5(18)6(3-17)20-7/h4-7,17-18H,2-3H2,1H3,(H2,12,14,15)/t5-,6+,7+/m0/s1
-
(2R,3R,4S,5R)-5-(6-aminopurin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-olCAS: 20227-41-2 分子式: C10H12FN5O3 分子量: 269.23期货 货号: F679264查看产品价格与包装技术标识符
- IUPAC名称
- (2R,3R,4S,5R)-5-(6-aminopurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol
- SMILES
- C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)F)N
- InChIKey
- ZGYYPTJWJBEXBC-GQTRHBFLSA-N
- InChI
- 1S/C10H12FN5O3/c11-5-7(18)4(1-17)19-10(5)16-3-15-6-8(12)13-2-14-9(6)16/h2-5,7,10,17-18H,1H2,(H2,12,13,14)/t4-,5+,7-,10-/m1/s1
-
5'-O-TBDMS-dA期货 货号: O646516查看产品价格与包装技术标识符
- IUPAC名称
- (2R,3S,5R)-5-(6-aminopurin-9-yl)-2-[[tert-butyl(dimethyl)silyl]oxymethyl]oxolan-3-ol
- SMILES
- CC(C)(C)[Si](C)(C)OCC1C(CC(O1)N2C=NC3=C(N=CN=C32)N)O
- InChIKey
- HGLRBQHXIBHZTD-QJPTWQEYSA-N
- InChI
- 1S/C16H27N5O3Si/c1-16(2,3)25(4,5)23-7-11-10(22)6-12(24-11)21-9-20-13-14(17)18-8-19-15(13)21/h8-12,22H,6-7H2,1-5H3,(H2,17,18,19)/t10-,11+,12+/m0/s1
-
dATPαS化合物 CID: 196416Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: D609746查看产品价格与包装技术标识符
- IUPAC名称
- [[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl] phosphono hydrogen phosphate
- SMILES
- O[C@H]1C[C@@H](O[C@@H]1COP(=S)(OP(=O)(OP(=O)(O)O)O)O)n1cnc2c1ncnc2N
- InChIKey
- CCPIKNHZOWQALM-DLQJRSQOSA-N
- InChI
- 1S/C10H16N5O11P3S/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(24-7)2-23-29(22,30)26-28(20,21)25-27(17,18)19/h3-7,16H,1-2H2,(H,20,21)(H,22,30)(H2,11,12,13)(H2,17,18,19)/t5-,6+,7+,29?/m0/s1
- 关联靶标
- P2Y purinoceptor 1
-
![[³⁵S]dATPαS](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/S/6/S614031.png)
[³⁵S]dATPαS化合物 CID: 10951309Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: S614031查看产品价格与包装技术标识符
- IUPAC名称
- ({[({[(2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)sulfanylidene-$l^{5}-phosphanyl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid
- SMILES
- O[C@H]1C[C@@H](O[C@@H]1COP(=[35S])(OP(=O)(OP(=O)(O)O)O)O)n1cnc2c1ncnc2N
- InChIKey
- CCPIKNHZOWQALM-XSYPLGNFSA-N
- InChI
- 1S/C10H16N5O11P3S/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(24-7)2-23-29(22,30)26-28(20,21)25-27(17,18)19/h3-7,16H,1-2H2,(H,20,21)(H,22,30)(H2,11,12,13)(H2,17,18,19)/t5-,6+,7+,29?/m0/s1/i30+3
-
2-氨基-2'-脱氧腺苷有现货 货号: R589163查看产品价格与包装技术标识符
- IUPAC名称
- (2R,3S,5R)-5-(2,6-diaminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
- SMILES
- C1C(C(OC1N2C=NC3=C(N=C(N=C32)N)N)CO)O
- InChIKey
- NOLHIMIFXOBLFF-KVQBGUIXSA-N
- InChI
- 1S/C10H14N6O3/c11-8-7-9(15-10(12)14-8)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H4,11,12,14,15)/t4-,5+,6+/m0/s1
快速发货
现货产品当日发货
技术详情
每个产品页均提供质量和规格信息
多种规格
多种包装规格和价格可选
仅供科研
产品仅供研发使用
危险品化学品经营许可证（带存储）